$1.82
-0.03-1.62%
In chiusura: -
$1.97
0.158.23%
After hour: 9:28 AM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
CASI Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 13
Stima EPS
$-0.400
Stima dei ricavi trimestrali
–
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$31.56M
Analizza lo storico degli utili di CASI Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
CASI | CASI Pharmaceuticals | -$0.55 | -$0.40 | — | — | $7.79M | — | — | — | 11/13/2025 | |
CASI | CASI Pharmaceuticals | -$0.52 | -$0.47 | -$0.86 | -82.98% | $3.98M | $6.28M | $4.17M | -33.49% | 08/29/2025 | |
CASI | CASI Pharmaceuticals | -$0.71 | -$0.60 | -$0.69 | -15.00% | $3.41M | $6.10M | $6.24M | 2.30% | 05/16/2025 | |
CASI | CASI Pharmaceuticals | -$0.45 | $0.00 | -$0.79 | -100.00% | $6.87M | $7.39M | $13.36M | 80.73% | 03/31/2025 | |
CASI | CASI Pharmaceuticals | -$0.35 | -$0.62 | -$0.55 | 11.29% | $8.84M | $4.56M | $7.79M | 70.90% | 11/15/2024 | |
CASI | CASI Pharmaceuticals | -$0.77 | -$0.63 | -$0.52 | 17.46% | $9.82M | $4.43M | $3.98M | -10.18% | 08/16/2024 | |
CASI | CASI Pharmaceuticals | -$0.45 | -$0.05 | -$0.71 | -1320.00% | $8.35M | $12.00M | $3.41M | -71.59% | 05/14/2024 | |
CASI | CASI Pharmaceuticals | -$1.44 | -$0.24 | -$0.45 | -87.50% | $15.26M | $9.41M | $6.87M | -26.95% | 03/28/2024 | |
CASI | CASI Pharmaceuticals | -$0.38 | -$0.56 | -$0.35 | 37.50% | $10.21M | $10.40M | $8.84M | -15.02% | 11/14/2023 | |
CASI | CASI Pharmaceuticals | -$0.56 | -$0.50 | -$0.77 | -54.00% | $8.57M | $10.09M | $9.82M | -2.68% | 08/11/2023 | |
CASI | CASI Pharmaceuticals | -$0.62 | -$0.64 | -$0.45 | 29.69% | $9.06M | $9.10M | $8.35M | -8.27% | 05/17/2023 | |
CASI | CASI Pharmaceuticals | -$0.40 | -$0.37 | -$1.44 | -289.19% | $9.16M | $10.79M | $15.26M | 41.42% | 04/26/2023 | |
CASI | CASI Pharmaceuticals | -$0.73 | -$0.46 | -$0.38 | 17.39% | $8.11M | $9.90M | $10.21M | 3.16% | 11/14/2022 | |
CASI | CASI Pharmaceuticals | -$0.40 | -$0.64 | -$0.56 | 12.50% | $7.16M | $7.87M | $8.57M | 8.93% | 08/12/2022 | |
CASI | CASI Pharmaceuticals | -$1.10 | -$0.90 | -$0.60 | 33.33% | $5.74M | $9.23M | $9.06M | -1.82% | 05/12/2022 | |
CASI | CASI Pharmaceuticals | -$1.20 | -$0.60 | -$0.40 | 33.33% | $4.82M | $9.07M | $9.16M | 0.97% | 03/28/2022 | |
CASI | CASI Pharmaceuticals | -$1.40 | -$0.50 | -$0.70 | -40.00% | $4.24M | $7.54M | $8.11M | 7.59% | 11/12/2021 | |
CASI | CASI Pharmaceuticals | -$0.90 | -$0.70 | -$0.50 | 28.57% | $2.67M | $6.02M | $7.16M | 18.97% | 08/12/2021 | |
CASI | CASI Pharmaceuticals | -$0.90 | -$0.60 | -$1.10 | -83.33% | $3.41M | $5.05M | $5.74M | 13.58% | 05/13/2021 | |
CASI | CASI Pharmaceuticals | -$1.30 | -$0.70 | -$1.20 | -71.43% | $1.34M | $4.45M | $4.82M | 8.36% | 03/30/2021 | |
CASI | CASI Pharmaceuticals | -$1.00 | -$0.50 | -$1.40 | -180.00% | $2.79M | $3.44M | $4.24M | 23.31% | 11/09/2020 |
CASI Pharmaceuticals (CASI) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-29 | $-0.86 | $-0.47 | -83.0 % |
| Q1 | 2025-05-16 | $-0.69 | $-0.60 | -15.0 % |
| Q4 | 2025-03-31 | $-0.79 | $0 | -100.0 % |
| Q3 | 2024-11-15 | $-0.55 | $-0.62 | 11.3 % |
CASI Pharmaceuticals (CASI) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-29 | $4.18M | $6.28M | -33.5 % |
| Q1 | 2025-05-16 | $6.24M | $6.10M | 2.30 % |
| Q4 | 2025-03-31 | $13.36M | $7.39M | 80.7 % |
| Q3 | 2024-11-15 | $7.79M | $4.56M | 70.9 % |
FAQ
Quando CASI Pharmaceuticals (NASDAQ:CASI) riporterà gli utili?
Si prevede che CASI Pharmaceuticals (CASI) fornisca risultati il novembre 13, 2025. Gli ultimi risultati sono stati pubblicati il agosto 29, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di CASI Pharmaceuticals (NASDAQ:CASI)?
L'EPS effettivo era $-0.86, che mancato la stima di $-0.47.
Quali sono state le entrate di CASI Pharmaceuticals (NASDAQ:CASI)?
Le entrate effettive sono state $4.2M, che mancato la stima di $6.3M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.